What is Functional Mobility Applied to Parkinson's Disease?

Journal of Parkinson's Disease
Raquel Bouça-MachadoJoaquim J Ferreira

Abstract

Although yet poorly defined and often misused, the concept of functional mobility has been used in research studies as a more global and ecological outcome of patients' health status. Functional mobility is a person's physiological ability to move independently and safely in a variety of environments in order to accomplish functional activities or tasks and to participate in the activities of daily living, at home, work and in the community. Parkinson's disease (PD) has a direct impact on patients' motor control and on mobility in general. Even with optimal medical management, the progression of PD is associated with mounting impairments at different levels of body function, causing marked limitations in a wide variety of activities, as well as a severe disability and loss of autonomy. Despite this, for everyday functioning PD patients need to have a good functional mobility that allow them to get around effortlessly in a reasonable amount of time to access to the same environments as others. This paper reviewed the concept of functional mobility applied to PD. This was done through an International Classification of Functioning and Disability (ICF) perspective. Recommendations to address the known factors that contribute to a ...Continue Reading

References

Feb 1, 1991·Journal of the American Geriatrics Society·D Podsiadlo, S Richardson
Mar 23, 2000·Journal of the Neurological Sciences·A L BehrmanK E Light
Jun 28, 2001·Clinical Biomechanics·M E MorrisR Iansek
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Margaret K Y Mak, Christina W Y Hui-Chan
Oct 23, 2003·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Anita D McQuillenBarbara G Licht
Oct 14, 2004·International Journal of Geriatric Psychiatry·Claire L LomaxRobert J Howard
Nov 30, 2006·Journal of Neurology·Werner Poewe
Feb 21, 2008·Clinical Rehabilitation·Colleen G CanningElke Woodhouse
Apr 11, 2008·American Journal of Physical Medicine & Rehabilitation·Claudine AugerFrank DeRuyter
Jun 30, 2009·Parkinsonism & Related Disorders·Brian K SchillingMichael J Falvo
Nov 4, 2009·Journal of the American Medical Directors Association·Mehmet Gürhan KarakayaAyşe Saadet Otman
Dec 22, 2009·Physical Therapy·Meg E MorrisMargaret L Schenkman
Jan 19, 2010·British Journal of Hospital Medicine·Sarah K Wilcox
Sep 10, 2010·Disability and Rehabilitation·Matilde LeonardiDomenico D'Amico
Mar 24, 2011·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Alberto RaggiLuigi Romito
May 23, 2012·Disability and Rehabilitation. Assistive Technology·Amit KumarMargo B Holm
May 7, 2013·Sleep Medicine·Maartje LouterSebastiaan Overeem
Jun 5, 2013·Best Practice & Research. Clinical Endocrinology & Metabolism·Mary Forhan, Simone V Gill
Oct 5, 2013·Continuum : Lifelong Learning in Neurology·David R Williams, Irene Litvan
Oct 18, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Fay B Horak, Martina Mancini
Nov 12, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V SpoorenbergS E Geerlings
Sep 6, 2014·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ryan P Duncan, Gammon M Earhart
Feb 11, 2015·Journal of Parkinson's Disease·Joaquim J FerreiraWalter Maetzler
Jun 24, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ari YlikoskiMarkku Partinen
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Dec 10, 2015·Neuroscience and Biobehavioral Reviews·Janet van UemWalter Maetzler
Mar 8, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Bastiaan R BloemUNKNOWN Movement Disorders Society Rating Scales Committee
Apr 1, 2016·Parkinsonism & Related Disorders·Janneke KoertsOliver Tucha
Apr 30, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Alberto J EspayUNKNOWN Movement Disorders Society Task Force on Technology
May 5, 2016·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Sang-I LinJau-Yih Tsauo
Jun 28, 2016·Neurology. Clinical Practice·Isabel BoersmaBenzi Kluger
Jul 13, 2016·Journal of Neurochemistry·Sigurlaug Sveinbjornsdottir
Jul 28, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Silvia Del DinLynn Rochester
Sep 20, 2016·Parkinsonism & Related Disorders·Aristide MerolaAlberto J Espay

❮ Previous
Next ❯

Citations

Feb 20, 2020·Movement Disorders Clinical Practice·Raquel Bouça-MachadoJoaquim J Ferreira
Aug 16, 2019·Medicina·David Suárez-IglesiasCarlos Ayán
Oct 22, 2020·JMIR Rehabilitation and Assistive Technologies·Matthew CzechShyamal Patel
Nov 17, 2020·Frontiers in Neurology·Raquel Bouça-MachadoJoaquim J Ferreira
Dec 23, 2020·Parkinsonism & Related Disorders·Peter A LeWitt, K Ray Chaudhuri
Mar 5, 2021·Current Neurology and Neuroscience Reports·Jamie L AdamsRuth B Schneider
Mar 21, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Elisa FrisaldiFabrizio Benedetti
Apr 10, 2021·Frontiers in Neurology·Raquel Bouça-MachadoUNKNOWN CNS Physiotherapy Study group
Jul 29, 2021·Clinical Parkinsonism & Related Disorders·Taylor L MyersRuth B Schneider

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.